Patients with cardiovascular disorders or psychiatric disorders should take Bromocriptine only if the benefits outweigh the potential risks. Blood pressure should be carefully monitored, especially during the first days of therapy. Specific caution is required in patients who are on concomitant therapy with medicines that can alter blood pressure.

Bromocriptine will efficiently lower prolactin levels in patients with pituitary tumours but does not prevent the requirement of radiotherapy or surgical intervention. Patients with rare hereditary problems of galactose intolerance or glucose-galactose malabsorption should not take this medicine.

Bromocriptine has been associated with somnolence and episodes of sudden sleep. Patients must be informed about this possibility and advised to take caution while driving or operating machines during treatment with Bromocriptine.